A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

Stanley Cohen

Annals of the Rheumatic Diseases · 2004 · 301 citations · 25 references

DOIFull text

Open access

Concepts

References

25